140 related articles for article (PubMed ID: 16054017)
1. Involvement of neutral endopeptidase in neoplastic progression.
Sumitomo M; Shen R; Nanus DM
Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
Sumitomo M; Shen R; Walburg M; Dai J; Geng Y; Navarro D; Boileau G; Papandreou CN; Giancotti FG; Knudsen B; Nanus DM
J Clin Invest; 2000 Dec; 106(11):1399-407. PubMed ID: 11104793
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
[TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
[TBL] [Abstract][Full Text] [Related]
5. Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.
Sumitomo M; Iwase A; Zheng R; Navarro D; Kaminetzky D; Shen R; Georgescu MM; Nanus DM
Cancer Cell; 2004 Jan; 5(1):67-78. PubMed ID: 14749127
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth.
Horiguchi A; Zheng R; Goodman OB; Shen R; Guan H; Hersh LB; Nanus DM
Cancer Gene Ther; 2007 Jun; 14(6):583-9. PubMed ID: 17415380
[TBL] [Abstract][Full Text] [Related]
7. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
Vazquez F; Sellers WR
Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
[No Abstract] [Full Text] [Related]
8. Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.
Mizerska-Kowalska M; Bojarska-Junak A; Jakubowicz-Gil J; Kandefer-Szerszeń M
Tumour Biol; 2016 Oct; 37(10):13355-13368. PubMed ID: 27460083
[TBL] [Abstract][Full Text] [Related]
9. Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.
Niv MY; Iida K; Zheng R; Horiguchi A; Shen R; Nanus DM
Protein Sci; 2009 May; 18(5):1042-50. PubMed ID: 19388049
[TBL] [Abstract][Full Text] [Related]
10. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.
Tamura M; Gu J; Danen EH; Takino T; Miyamoto S; Yamada KM
J Biol Chem; 1999 Jul; 274(29):20693-703. PubMed ID: 10400703
[TBL] [Abstract][Full Text] [Related]
11. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
12. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
[TBL] [Abstract][Full Text] [Related]
13. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.
Iwase A; Shen R; Navarro D; Nanus DM
J Biol Chem; 2004 Mar; 279(12):11898-905. PubMed ID: 14704146
[TBL] [Abstract][Full Text] [Related]
16. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
17. Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase.
Shen R; Milowsky MI; Ozaki N; Navarro D; Sumitomo M; Xu Y; Nanus DM
Anticancer Res; 2002; 22(5):2533-8. PubMed ID: 12529960
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
[TBL] [Abstract][Full Text] [Related]
19. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
20. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness.
Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E
FASEB J; 2005 Jan; 19(1):115-7. PubMed ID: 15629897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
